» Articles » PMID: 25311695

Cryptosporidium Muris: Infectivity and Illness in Healthy Adult Volunteers

Overview
Specialty Tropical Medicine
Date 2014 Oct 15
PMID 25311695
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Although Cryptosporidium parvum and C. hominis cause the majority of human cryptosporidiosis cases, other Cryptosporidium species are also capable of infecting humans, particularly when individuals are immunocompromised. Ten C. muris cases have been reported, primarily in human immunodeficiency virus (HIV) -positive patients with diarrhea. However, asymptomatic cases were reported in two HIV-negative children, and in another case, age and immune status were not described. This study examines the infectivity of C. muris in six healthy adults. Volunteers were challenged with 10(5) C. muris oocysts and monitored for 6 weeks for infection and/or illness. All six patients became infected. Two patients experienced a self-limited diarrheal illness. Total oocysts shed during the study ranged from 6.7 × 10(6) to 4.1 × 10(8), and the number was slightly higher in volunteers with diarrhea (2.8 × 10(8)) than asymptomatic shedders (4.4 × 10(7)). C. muris-infected subjects shed oocysts longer than occurred with other species studied in healthy volunteers. Three volunteers shed oocysts for 7 months. Physical examinations were normal, with no reported recurrence of diarrhea or other gastrointestinal complaints. Two persistent shedders were treated with nitazoxanide, and the infection was resolved. Thus, healthy adults are susceptible to C. muris, which can cause mild diarrhea and result in persistent, asymptomatic infection.

Citing Articles

Prevalence and genotype analysis of Cryptosporidium spp. in nine species of wild rodents in China.

Gao Z, Wang H, Li J, Song Y, Hou Q, Qin S Parasite. 2025; 32:19.

PMID: 40053847 PMC: 11888585. DOI: 10.1051/parasite/2025012.


Cryptosporidiosis in individuals with inflammatory bowel disease: a scoping review protocol.

Liu B, Schnider A, DeArmond M, Banach D, Haubrich B BMJ Open. 2024; 14(10):e086529.

PMID: 39414295 PMC: 11481120. DOI: 10.1136/bmjopen-2024-086529.


Molecular characterization of in wild rodents from the Inner Mongolian Autonomous Region and Liaoning Province, China: assessing host specificity and the potential for zoonotic transmission.

Liu L, Xu Q, Jiang A, Zeng F, Zhao W, Tan F Front Vet Sci. 2024; 11:1406564.

PMID: 38872807 PMC: 11169895. DOI: 10.3389/fvets.2024.1406564.


Molecular Detection and Genotyping of Cryptosporidium spp. Isolates from Bats in Colombia.

Silva-Ramos C, Noriega J, Fajardo R, Chala-Quintero S, Pulido-Villamarin A, Perez-Torres J Acta Parasitol. 2023; 68(3):676-682.

PMID: 37531008 PMC: 10462512. DOI: 10.1007/s11686-023-00697-8.


Detection and Molecular Characterization of and spp. Circulating in Wild Small Mammals from Portugal.

Lux L, Ulrich R, Santos-Silva S, Queiros J, Imholt C, Klotz C Animals (Basel). 2023; 13(3).

PMID: 36766405 PMC: 9913638. DOI: 10.3390/ani13030515.


References
1.
Giles M, Webster K, Marshall J, Catchpole J, Goddard T . Experimental infection of a lamb with Cryptosporidium parvum genotype 1. Vet Rec. 2001; 149(17):523-5. DOI: 10.1136/vr.149.17.523. View

2.
White Jr A . Nitazoxanide: an important advance in anti-parasitic therapy. Am J Trop Med Hyg. 2003; 68(4):382-3. View

3.
Neira O P, Munoz S N, Wilson L G, Barthel M M, Rosales L M, Henriquez R C . [Cryptosporidium species in immunodeficient and immunocompetent patients of Valparaíso: a descriptive study]. Rev Chilena Infectol. 2012; 29(1):63-71. DOI: 10.4067/S0716-10182012000100011. View

4.
Chappell C, Okhuysen P, Sterling C, Wang C, Jakubowski W, DuPont H . Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G. Am J Trop Med Hyg. 1999; 60(1):157-64. DOI: 10.4269/ajtmh.1999.60.157. View

5.
Nime F, Burek J, Page D, Holscher M, Yardley J . Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology. 1976; 70(4):592-8. View